Skip to main content
. Author manuscript; available in PMC: 2016 Feb 9.
Published in final edited form as: J Neurosurg. 2013 Apr 26;119(2):427–433. doi: 10.3171/2013.3.JNS122226

TABLE 2.

Histological and immunohistochemical findings

Vascular Immunohistochemical Features

Tumor Type Vascular & Glial Morphology CD31 GFAP AQ4
metastasis thin-walled vessels, no astrocytes w/in lesion positive staining of thin-walled vessel no staining w/in bulk of lesion, but reconstitution of astrocytic processes at metastasis-brain interface no staining w/in bulk of lesion, but reconstitution of normal basement membrane at metastasis-brain interface
low-grade glioma normal-appearing vasculature (endothelial cells), astrocytes w/ normal elongated processes apposing each other & tightly associated w/ the vasculature w/in lesion positive staining of normal-appearing vasculature w/in region of tumor staining of astrocytic process tightly associated w/ vessels w/in scattered neoplastic cells w/ dysmorphic nuclei intense staining surrounding vasculature throughout lesion
malignant glioma* enhancing region scattered glomeruloid & thick-walled vessels, absence of normal astrocyte architecture positive staining of thick-walled vasculature, including capillaries diffuse staining, associated w/ neoplastic cells, no discernible elongated astrocytic processes, gaps in staining surrounding vasculature diffuse AQ4 staining associated w/ neoplastic cells, gaps of AQ4 staining surrounding vasculature
  nonenhancing region normal-appearing cerebral vasculature, astrocytes w/ normal elongated processes apposing each other & tightly associated w/ vasculature w/in nonenhancing portions of lesion positive staining of normal- appearing vasculature staining of glial processes, tightly associated w/ vessels, together w/ scattered staining of neoplastic cells w/ dysmorphic nuclei intense staining surrounding vasculature throughout lesion
*

Enhancing region: contrast enhancement on MRI after intravenous contrast administration. Nonenhancing region: lack of contrast enhancement on MRI after intravenous contrast administration.